TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29496652

Group type: EXPERIMENTAL
Intervention: Exemplar messages for tobacco module
Number of subjects: 1945

Group type: EXPERIMENTAL
Intervention: Messages with tailored priming and an exemplar for tobacco module
Number of subjects: 1945

Group type: EXPERIMENTAL
Intervention: Standard priming with autonomy supportive and exemplar messages for PA, eating habits, and weight
Number of subjects: 1945

Group type: EXPERIMENTAL
Intervention: Autonomy supportive messages for PA module
Number of subjects: 1945

Group type: EXPERIMENTAL
Intervention: Exemplar messages for PA, eating habits, and weight-related behaviors
Number of subjects: 1945

Group type: COMPARATOR
Intervention: Different message conditions
Number of subjects: 1945
Study: 25846254

Group type: EXPERIMENTAL
Intervention: Intraoral cementation
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Extraoral cementation
Number of subjects: 46
Study: 24827128

Group type: EXPERIMENTAL
Intervention: EC-Doc (4 × E90C600 q3w followed by 4 × docetaxel 100 q3w, n = 1008)
Number of subjects: 2011

Group type: COMPARATOR
Intervention: FEC (6 × F500E100C500 q3w or C600M40F600 d1, 8× q4w, n = 828 or n = 175)
Number of subjects: 2011

Group type: EXPERIMENTAL
Intervention: EC-Doc (in HR+ disease with high-Ki-67 tumors)
Number of subjects: 2011
Study: 23185762

Group type: EXPERIMENTAL
Intervention: Yiqi Huoxue Qufeng Decoction (YHQD), one dose daily, once in the morning and once in the evening for 8 weeks
Number of subjects: 85

Group type: COMPARATOR
Intervention: Fuyang Granule (FYG), 6 g each time, three times daily for 8 weeks
Number of subjects: 85
Study: 20637961

Group type: EXPERIMENTAL
Intervention: Somatropin (0.033 mg/kg/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study: 17922167

Group type: EXPERIMENTAL
Intervention: General recommendation-based program of lifestyle intervention carried out by trained professionals
Number of subjects: 335

Group type: COMPARATOR
Intervention: Standard unstructured information given by family physicians
Number of subjects: 335
Study: 15675986

Group type: EXPERIMENTAL
Intervention: L3/4T group (4 mg hyperbaric bupivacaine, head-down tilt)
Number of subjects: 123

Group type: COMPARATOR
Intervention: L2/3 group (4 mg hyperbaric bupivacaine, horizontal)
Number of subjects: 123

Group type: COMPARATOR
Intervention: L3/4H group (4 mg hyperbaric bupivacaine, horizontal)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 123
Study: 11869921

Group type: EXPERIMENTAL
Intervention: Telephone notification
Number of subjects: 351

Group type: COMPARATOR
Intervention: Face-to-face notification
Number of subjects: 351
Study: 10432476

Group type: EXPERIMENTAL
Intervention: High dose naloxone administered immediately before ECT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low dose naloxone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High dose naloxone
Number of subjects: 0
Study: 7488341

Group type: EXPERIMENTAL
Intervention: Cyproheptadine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ketotifen
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Both Cyproheptadine and Ketotifen
Number of subjects: 6
Study: 31354858

Group type: EXPERIMENTAL
Intervention: Qingshen Granules (QSG), 10 g oral doses, 3 times a day for 12 weeks
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Qingshen Granules (QSG)
Number of subjects: 84
Study: 30480595

Group type: EXPERIMENTAL
Intervention: ORTSD fixation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 60
Study: 26952241

Group type: EXPERIMENTAL
Intervention: Age <45 years
Number of subjects: 7141

Group type: EXPERIMENTAL
Intervention: Age 45 to <55 years
Number of subjects: 7141

Group type: EXPERIMENTAL
Intervention: Age ≥75 years
Number of subjects: 7141

Group type: EXPERIMENTAL
Intervention: Age ≥55 years
Number of subjects: 7141

Group type: EXPERIMENTAL
Intervention: Age <55 years
Number of subjects: 7141
Study: 25310118

Group type: EXPERIMENTAL
Intervention: Continuous quality improvement/Breakthrough Series intervention
Number of subjects: 32

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 32
Study: 22545736

Group type: EXPERIMENTAL
Intervention: SMS-based maintenance intervention
Number of subjects: 165
Study: 19772799

Group type: EXPERIMENTAL
Intervention: MTX information booklet (active-arm)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control-arm (no MTX information booklet)
Number of subjects: 78
Study: 17326150

Group type: EXPERIMENTAL
Intervention: Lactulose treatment for 3 months (n=31)
Number of subjects: 90

Group type: COMPARATOR
Intervention: No treatment (control group, n=30)
Number of subjects: 90
Study: 15465941

Group type: EXPERIMENTAL
Intervention: Open access system for outpatient appointments
Number of subjects: 30

Group type: COMPARATOR
Intervention: Fixed outpatient appointments
Number of subjects: 30
Study: 11465625

Group type: EXPERIMENTAL
Intervention: Low preoperative serum antiendotoxin core antibody (EndoCAb) concentration
Number of subjects: 1056

Group type: EXPERIMENTAL
Intervention: POSSUM physiologic risk score
Number of subjects: 1056

Group type: EXPERIMENTAL
Intervention: Total immunoglobulin M and total immunoglobulin G concentrations
Number of subjects: 1056
Study: 9740922

Group type: EXPERIMENTAL
Intervention: Normal saline solution (0.9% sodium chloride)
Number of subjects: 0
Study: 7979616

Group type: EXPERIMENTAL
Intervention: Preoperative radiation therapy (500 cGy)
Number of subjects: 301

Group type: COMPARATOR
Intervention: No preoperative therapy
Number of subjects: 301
Study: 3055924

Group type: EXPERIMENTAL
Intervention: Nifedipine-propranolol combination therapy
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Diltiazem-propranolol combination therapy
Number of subjects: 19

Group type: COMPARATOR
Intervention: High dose diltiazem monotherapy
Number of subjects: 19
Study: 4808815

Group type: EXPERIMENTAL
Intervention: Aspirin (600 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Aspirin (300 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Aspirin and ethanol (combined)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ethanol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sodium acetylsalicylate
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Phenylbutazone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Long-term aspirin and prednisone (patients)
Number of subjects: 20
Study: 30884986

Group type: EXPERIMENTAL
Intervention: Pertuzumab with trastuzumab and chemotherapy (THP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trastuzumab and chemotherapy (TH)
Number of subjects: 0
Study: 28088957

Group type: EXPERIMENTAL
Intervention: Subserosal injection of carbon nanoparticles around the tumor one day before the operation (trial group)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Routine laparoscopic gastrectomy (control group)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Subserosal injection of carbon nanoparticles (trial group)
Number of subjects: 78
Study: 25155895

Group type: EXPERIMENTAL
Intervention: Drug therapy monitoring (DTMG)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Health education (HEG)
Number of subjects: 200
Study: 23394573

Group type: EXPERIMENTAL
Intervention: Training and support in the provision of brief lifestyle assessments and interventions
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group provided usual care
Number of subjects: 129
Study: 21477065

Group type: EXPERIMENTAL
Intervention: GMP (1 or 2 mg glimepiride, 500 mg sustained-release metformin, and 15 mg pioglitazone administered once daily)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: GMP
Number of subjects: 101

Group type: COMPARATOR
Intervention: IM (human insulin 70/30 mix and 500 mg sustained-release metformin administered twice daily)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: GMP and IM
Number of subjects: 101

Group type: COMPARATOR
Intervention: IM
Number of subjects: 101
Study: 18094223

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate hydrofluoroalkane 88 mug twice a day
Number of subjects: 79

Group type: COMPARATOR
Intervention: Fluticasone propionate chlorofluorocarbon 88 mug twice a day
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 17052048

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 0
Study: 14603059

Group type: EXPERIMENTAL
Intervention: Titanium implants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Polylactide resorbable plates
Number of subjects: 0

Group type: COMPARATOR
Intervention: Silicone pressure equalizing tube
Number of subjects: 0
Study: 10813165

Group type: EXPERIMENTAL
Intervention: Intramedullary nail (IMN)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Dynamic compression plate (DCP)
Number of subjects: 44
Study: 8985795

Group type: EXPERIMENTAL
Intervention: Perceived overprotectiveness by wives
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Wives' perception of overprotectiveness
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Patients' perception of overprotectiveness at 3 months
Number of subjects: 52
Study: 1476280

Group type: EXPERIMENTAL
Intervention: Ondansetron 8 mg orally 1 hour before surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 6086466

Group type: EXPERIMENTAL
Intervention: Oral rehydration solution containing 2.94 g sodium citrate per litre
Number of subjects: 40

Group type: COMPARATOR
Intervention: WHO recommended oral rehydration solution containing 2.5 g sodium bicarbonate per litre
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both sodium citrate and sodium bicarbonate solutions
Number of subjects: 40
Study: 30371826

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Treatment (CBT)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Treatment + Contingency Management (CBT + CM)
Number of subjects: 205
Study: 29948355

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Splinting
Number of subjects: 44
Study: 26260038

Group type: EXPERIMENTAL
Intervention: Lowered threshold group
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Raised threshold group
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2
Study: 24761794

Group type: EXPERIMENTAL
Intervention: exoU(+) strains
Number of subjects: 0

Group type: COMPARATOR
Intervention: exoU(‐) strains
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Infections involving resistant exoU(+) strains
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laboratory isolates with exoU gene modification
Number of subjects: 0
Study: 21770835

Group type: EXPERIMENTAL
Intervention: Early high doses parenteral nutrition (3.0 g/kg/day amino acids and 3 g/kg/day of 20% lipid)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Early low dose parenteral nutrition (1 g/kg/day amino acids and lipid, advanced to 3 g/kg/day over 3 days)
Number of subjects: 41
Study: 20977130

Group type: EXPERIMENTAL
Intervention: 50 mg of oral meclizine (experimental group)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 70
Study: 18834238

Group type: COMPARATOR
Intervention: Free Gingival Graft (FGG)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Bilayered Cell Therapy (BCT)
Number of subjects: 25
Study: 14697473

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day for 6 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 11897906

Group type: EXPERIMENTAL
Intervention: Antiphospholipid antibodies (aPL) presence in women undergoing IVF‐ET
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine screening for aPL
Number of subjects: 0
Study: 9834049

Group type: EXPERIMENTAL
Intervention: 750 microg/kg CP‐99,994 infused intravenously over 5 hours on a tapering regimen starting 2 hours before surgery
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: 600 mg oral ibuprofen 30 minutes before surgery
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 8077892

Group type: EXPERIMENTAL
Intervention: Sucralfate suspension
Number of subjects: 21

Group type: COMPARATOR
Intervention: Antacid solution
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 2671083

Group type: EXPERIMENTAL
Intervention: Stimulant medication
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 14049

Group type: COMPARATOR
Intervention: neomycin-sorbitol
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: lactulose
Number of subjects: 33
Study: 28527751

Group type: EXPERIMENTAL
Intervention: Finger flexion exercise using elastic resistance
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Finger extension exercise using elastic resistance
Number of subjects: 18
Study: 27792023

Group type: EXPERIMENTAL
Intervention: Double straps with the backpack worn midline on the back with one strap over each shoulder
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Single strap with the backpack worn laterally with one strap over the shoulder
Number of subjects: 18
Study: 24738319

Group type: EXPERIMENTAL
Intervention: Absorbable shanching satin rb-bFGF prepreg sheet and expansion hemostatic sponge
Number of subjects: 96

Group type: COMPARATOR
Intervention: Vaseline gauze nasal packing
Number of subjects: 96
Study: 23496212

Group type: EXPERIMENTAL
Intervention: Ginger (2 g/d)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 20421723

Group type: EXPERIMENTAL
Intervention: Shan 4
Number of subjects: 210

Group type: COMPARATOR
Intervention: EasyFour
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Shan 4 and EasyFour
Number of subjects: 210
Study: 19038901

Group type: EXPERIMENTAL
Intervention: Elderly adults (age 65 and older)
Number of subjects: 352
Study: 15864218

Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg/day)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Coinfusion of ACh plus vitamin C
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: l-NMMA (NO-synthase inhibitor)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Cerivastatin (0.4 mg/day)
Number of subjects: 41
Study: 12935384

Group type: EXPERIMENTAL
Intervention: Emotion-focused coping
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Time since HIV diagnosis
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Interaction effect of time and coping
Number of subjects: 179
Study: 10759665

Group type: COMPARATOR
Intervention: Placebo tablet twice a day for 3 days
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Single dose of ciprofloxacin (500 mg) and tinidazole (600 mg)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin-tinidazole combination twice a day for 3 days
Number of subjects: 231
Study: 8628089

Group type: EXPERIMENTAL
Intervention: Oxymetazoline nasal spray
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Benzalkonium chloride nasal spray
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 30
Study: 1466465

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine with 100 micrograms epinephrine (group 2)
Number of subjects: 47

Group type: COMPARATOR
Intervention: 3 mg morphine sulfate and 100 micrograms epinephrine in normal saline (group 3)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Normal saline with 100 micrograms epinephrine (group 1)
Number of subjects: 47
Study: 6362815

Group type: EXPERIMENTAL
Intervention: Adriamycin and cyclophosphamide (AC)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Hydroxyurea (H)
Number of subjects: 158
Study: 31565116

Group type: EXPERIMENTAL
Intervention: Women aged 26 years and above
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Women with good knowledge on breast cancer risk factors
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Women who had ever heard about breast cancer screening
Number of subjects: 422
Study: 28893676

Group type: EXPERIMENTAL
Intervention: Positive skill-building activities
Number of subjects: 360

Group type: COMPARATOR
Intervention: Neutral control activities
Number of subjects: 360
Study: 26694939

Group type: EXPERIMENTAL
Intervention: Aprepitant 80 mg orally with ondansetron 4 mg intravenously
Number of subjects: 125

Group type: COMPARATOR
Intervention: Ondansetron 4 mg intravenously
Number of subjects: 125
Study: 24566504

Group type: EXPERIMENTAL
Intervention: Peer-led self-management intervention (Building Recovery of Individual Dreams and Goals Through Education and Support)
Number of subjects: 428

Group type: COMPARATOR
Intervention: Services as usual
Number of subjects: 428
Study: 21984038

Group type: EXPERIMENTAL
Intervention: Letrozole (2.5 mg)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Clomiphene citrate (100 mg)
Number of subjects: 147
Study: 20200816

Group type: EXPERIMENTAL
Intervention: L-methionine (0.1 g/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 30
Study: 18991518

Group type: EXPERIMENTAL
Intervention: T'ai chi (TC) exercise, 90-minute sessions weekly for 9 months
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (normal daily physical activity)
Number of subjects: 61
Study: 15767195

Group type: EXPERIMENTAL
Intervention: Breast cushions used during mammography
Number of subjects: 394
Study: 11815494

Group type: EXPERIMENTAL
Intervention: Individual education
Number of subjects: 170

Group type: COMPARATOR
Intervention: Group education
Number of subjects: 170
Study: 9917122

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillators
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antiarrhythmic medications
Number of subjects: 0

Group type: COMPARATOR
Intervention: β-blockers or verapamil
Number of subjects: 0
Study: 7481022

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 40
Study: 3556261

Group type: EXPERIMENTAL
Intervention: 200 mg pivmecillinam/250 mg pivampicillin given twice daily
Number of subjects: 3783

Group type: COMPARATOR
Intervention: 250 mg amoxycillin given three times daily
Number of subjects: 3783
Study: 30249389

Group type: EXPERIMENTAL
Intervention: Ibrutinib 420 mg/day
Number of subjects: 391

Group type: COMPARATOR
Intervention: Ofatumumab
Number of subjects: 391

Group type: EXPERIMENTAL
Intervention: Ibrutinib
Number of subjects: 391
Study: 26992879

Group type: EXPERIMENTAL
Intervention: Adherence therapy (8 sessions)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no adherence therapy)
Number of subjects: 30
Study: 25965108

Group type: EXPERIMENTAL
Intervention: Yoga exercise
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (women without PMS)
Number of subjects: 11
Study: 23320746

Group type: EXPERIMENTAL
Intervention: Number of diseases
Number of subjects: 733

Group type: EXPERIMENTAL
Intervention: Urinary incontinence
Number of subjects: 733

Group type: EXPERIMENTAL
Intervention: Antidepressant use
Number of subjects: 733

Group type: EXPERIMENTAL
Intervention: Arrhythmias
Number of subjects: 733

Group type: EXPERIMENTAL
Intervention: Polypharmacy
Number of subjects: 733

Group type: EXPERIMENTAL
Intervention: Number of diseases (with reference to those with ≤ 1 condition)
Number of subjects: 733
Study: 20502133

Group type: EXPERIMENTAL
Intervention: Tolcapone (as an adjunct to l-dopa)
Number of subjects: 150
Study: 19097508

Group type: EXPERIMENTAL
Intervention: Subcutaneous penetration needling
Number of subjects: 66

Group type: COMPARATOR
Intervention: Straight needling
Number of subjects: 66
Study: 20659697

Group type: EXPERIMENTAL
Intervention: Thalidomide 1% paste
Number of subjects: 69

Group type: COMPARATOR
Intervention: Dexamethasone 0.043% paste
Number of subjects: 69
Study: 16282232

Group type: EXPERIMENTAL
Intervention: Every 4th day bathing (intervention group, n = 25)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Every other day bathing (control group, n = 28)
Number of subjects: 53
Study: 12144575

Group type: EXPERIMENTAL
Intervention: Triple therapy (omeprazole 20 mg, amoxicillin 1 g, clarithromycin 500 mg, all b.d.)
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Quadruple therapy (omeprazole 20 mg b.d., tetracycline chloride 500 mg, metronidazole 500 mg, bismuth subcitrate 120 mg, all t.d.s.)
Number of subjects: 339
Study: 9447610

Group type: EXPERIMENTAL
Intervention: SMA III patients with disease duration of < or = 11 years
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: SMA III patients with disease duration of > or = 16 years
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: SMA III patients with disease onset at < or = 3 years of age
Number of subjects: 26

Group type: COMPARATOR
Intervention: SMA III patients
Number of subjects: 26
Study: 8188493

Group type: EXPERIMENTAL
Intervention: Brief supportive telephone counseling (3 calls)
Number of subjects: 0
Study: 3163501

Group type: EXPERIMENTAL
Intervention: Nalbuphine (0.2 mg/kg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pentazocine (0.5 mg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Midazolam alone (historical control)
Number of subjects: 40
Study: 11684628

Group type: EXPERIMENTAL
Intervention: Vitamin C treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29671035

Group type: EXPERIMENTAL
Intervention: StO2 <75%
Number of subjects: 60

Group type: COMPARATOR
Intervention: StO2 ≥75%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: StO2
Number of subjects: 60
Study: 29311053

Group type: EXPERIMENTAL
Intervention: 2 years of exercise training (n=34)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Attention control (n=27)
Number of subjects: 61
Study: 26764065

Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 220

Group type: COMPARATOR
Intervention: PCI
Number of subjects: 220

Group type: COMPARATOR
Intervention: PCI vs CABG
Number of subjects: 220
Study: 24911432

Group type: EXPERIMENTAL
Intervention: Dabigatran 150 mg BID
Number of subjects: 70000

Group type: EXPERIMENTAL
Intervention: Apixaban BID
Number of subjects: 70000

Group type: EXPERIMENTAL
Intervention: BID dosing regimen
Number of subjects: 70000

Group type: COMPARATOR
Intervention: BID dosing regimen vs rivaroxaban QD
Number of subjects: 70000

Group type: COMPARATOR
Intervention: BID dosing regimen vs edoxaban QD
Number of subjects: 70000

Group type: COMPARATOR
Intervention: Non-vitamin K antagonist oral anticoagulants vs warfarin
Number of subjects: 70000
Study: 23654014

Group type: EXPERIMENTAL
Intervention: Early multimodal accelerated rehabilitation program (mean duration 7.24 days)
Number of subjects: 58